The Canadian Startup Conquering Missed Concussion Diagnoses, One Spit Test at a Time
Head games.
Head games.
Medicine
A New Treatment Cures an Old Disease—and Possibly Many Others
Casgevy is the world’s first government-approved, effective gene-edited cell therapy to treat sickle-cell disease.
Casgevy is the world’s first government-approved, effective gene-edited cell therapy to treat sickle-cell disease.
Psychedelics Have Positively Impacted Mental Health in Canada—What Else Will They Change?
Long stigmatized, these substances are coming into the mainstream. We talk with the experts about the future of their recreational, therapeutic, and business potentials.
A New Weapon In The War Against Cancer
Caspase-independent cell death as an alternative to chemotherapy.
Researchers at the University of Glasgow have developed a new weapon in humanity’s ongoing war against cancer.
Robots and the Future of Dying
How artificial intelligence is changing end of life care.
As the world’s aging population grows, a new host of tools designed for the dying has emerged.
The Doctor Is In
Medicine gets personal.
Thirteen years, three billion dollars. That’s the size of the investment made to map the human genome in its entirety, give or take a few months and a few million. While scientists completed the effort over a decade ago, we’re only starting to reap the returns.
